Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
Poulter CA, Cosmatos D, Rubin P, Urtasun R, Cooper JS, Kuske RR, Hornback N, Coughlin C, Weigensberg I, Rotman M. Poulter CA, et al. Among authors: hornback n. Int J Radiat Oncol Biol Phys. 1992;23(1):207-14. doi: 10.1016/0360-3016(92)90563-w. Int J Radiat Oncol Biol Phys. 1992. PMID: 1374061 Clinical Trial.
Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
Bauer M, Leibel S, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Conner N, Pakuris E, et al. Bauer M, et al. Among authors: hornback n. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1101-3. doi: 10.1016/0360-3016(86)90235-x. Int J Radiat Oncol Biol Phys. 1986. PMID: 3528087 Clinical Trial.
Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Pakuris E, Conner N, et al. Leibel S, et al. Among authors: hornback n. Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):541-9. doi: 10.1016/0360-3016(87)90069-1. Int J Radiat Oncol Biol Phys. 1987. PMID: 3104249 Clinical Trial.
Whole body hyperthermia: a potent radioprotector in vivo.
Shen RN, Hornback NB, Shidnia H, Wu B, Lu L, Broxmeyer HE. Shen RN, et al. Among authors: hornback nb. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):525-30. doi: 10.1016/0360-3016(91)90065-c. Int J Radiat Oncol Biol Phys. 1991. PMID: 1995538
69 results